Oct 29,2020

Voluntis and Redox enter into new partership to enable interoperability of digital therapeutics with Electronic Health Records

Voluntis, a leader in digital therapeutics, announced today its strategic partnership with Redox, the leading interoperability platform for healthcare data exchange. The partnership will allow providers to automate and adapt insights on their patients’ treatment journey within their Electronic Health Records (EHR) to enhance care and collaboration.

COLLABORATION PARTNERSHIP

#product & service

#software

View Analyst & Ambassador Comments
Go to original news
Nov 15,2020

CMIC Supports Clinical Trials for Digital Therapeutics Using SUSMED’s Trial Management System

CMIC Co., Ltd. has launched services using SUSMED, Inc.’s trial management system covering subject registration, software assignment and distribution for digital therapeutics (DTx). The system is able to overcome the common challenges of DTx clinical trials, ensuring blinded assignment and preventing unauthorized access. By employing this system, CMIC will offer more efficient operations for DTx trials, such as for the assignment and delivery of software applications (apps) to trial participants, cutting development costs.

COLLABORATION PARTNERSHIP

#r&d

#software

View Analyst & Ambassador Comments
Go to original news
Nov 16,2020

Accenture, Orexo Team to Offer Digital Therapeutics Through INTIENT™ Platform

Accenture (NYSE: ACN) has helped the U.S. subsidiary of Swedish pharmaceutical company Orexo launch its first digital therapeutic, vorvida®, for patients in the United States dealing with problematic alcohol use. vorvida® is a web-based digital platform that uses the INTIENT™ Patient solution suite, which is powered by Google Cloud, to enable secure patient interactions and connectivity to an ecosystem of third-party health care services. The INTIENT Patient solution suite is part of Accenture’s INTIENT™ platform, which supports the life science industry by providing cloud-based solutions for industry needs across R&D and Commercial.

COLLABORATION PARTNERSHIP

#r&d

#software

View Analyst & Ambassador Comments
Go to original news
Nov 17,2020

MedRhythms, Roux Institute Partner in the Fields of Neuroscience, Artificial Intelligence

MedRhythms, a digital therapeutics company building direct stimulation solutions to help restore function lost to neurologic disease or injury, today announced a partnership with the Roux Institute by Northeastern University. The partnership will generate strategic research collaborations between the two organizations and provide co-op opportunities with MedRhythms to Roux Institute students, thus increasing MedRhythms’ advanced technology and life sciences talent pipeline, as well.

COLLABORATION PARTNERSHIP

#r&d

#software

View Analyst & Ambassador Comments
Go to original news
Nov 18,2020

Voluntis: Launch of a New R&D Program to Extend the Theraxium Platform Supported by a Loan from Bpifrance

Voluntis today announced the launch of a new R&D program to advance the capabilities of its Theraxium platform. It also announced a new loan obtained from Bpifrance to support its innovation program. The new features in Theraxium developed by Voluntis will be gradually made available to life science partners and end users starting in 2021, initially as part of pilot deployments in collaboration with select oncology centers. To support this program, Voluntis has obtained a new R&D Innovation loan from Bpifrance Financement. This €1 million loan has a term of six years and two months.

#software

View Analyst & Ambassador Comments
Go to original news
Dec 08,2020

Ehave, Inc. and Identity Key Announce Partnership for Blockchain Based Identity Verification Software for the Medical Industry

Ehave, a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced it has entered into a partnership with Identity Key to provide blockchain based identity verification software for the medical industry.

COLLABORATION PARTNERSHIP

#product & service

#software

View Analyst & Ambassador Comments
Go to original news
Dec 14,2020

Welldoc Submits 510(k) for Bolus and Premixed Insulin Titration Program as Part of BlueStar®

Welldoc®, a trailblazer in digital health that is revolutionizing chronic disease management to help transform lives, today announced the filing of its ninth 510(k) with the U.S. Food and Drug Administration (FDA) for BlueStar, an FDA-cleared digital health solution for diabetes. With the filing, BlueStar looks to add bolus and premixed insulin titration for type 2 diabetes to its comprehensive diabetes platform. In June, Welldoc announced FDA clearance for the BlueStar Insulin Adjustment Program for basal insulin titration. This current submission would expand insulin dosing support to include most types of insulin. The 510(k) was submitted on Nov 23, 2020.

PRODUCT

#rpm

#software

View Analyst & Ambassador Comments
Go to original news
Dec 22,2020

DarioHealth Announces Agreement With Presbyterian Medical Services for Remote Patient Monitoring

DarioHealth Corp., a pioneer in the global digital therapeutics (DTx) market, announced that the Company has entered into an agreement to provide its remote patient monitoring (RPM) solution to Presbyterian Medical Services, one of the largest integrated healthcare systems in the State of New Mexico, effective January 1, 2021.

COLLABORATION PARTNERSHIP

#institution

#rpm

#software

View Analyst & Ambassador Comments
Go to original news
Dec 18,2019

Voluntis announces new pharma collaboration in oncology

Voluntis, a leader in digital therapeutics, announced today a collaboration with Novartis to evaluate the use of Voluntis’ digital therapeutic platform for Breast Cancer patients with the goal to empower patients with tools to more effectively manage symptoms and, thereby, improve patient experience and outcomes. This collaboration will leverage Voluntis’ Theraxium Oncology, the company’s core platform for digital therapeutics in the field of oncology.

COLLABORATION PARTNERSHIP

#r&d

#software

#rpm

View Analyst & Ambassador Comments
Go to original news
Nov 25,2019

DarioHealth® Introduces "Membership-in-a-Box" to Brick and Mortar Retailers

Global digital therapeutics innovation leader, DarioHealth, announced today that its online membership offering will now be available for purchase in physical retail stores. The "Membership-in-a-Box" (MIB) package was designed to reach consumers with chronic conditions such as diabetes who shop at retail stores. MIB plans are currently available for three-month periods through Best Buy Online. Once the initial period finishes, members have the option to renew the service through Dario.

PRODUCT

#software

#coaching

View Analyst & Ambassador Comments
Go to original news
Subscribe to SOFTWARE